Cargando…
Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report
RATIONALE: Veno-occlusive disease (VOD) is characterized by painful hepatomegaly, ascites, weight gain, and jaundice with nonthrombotic, fibrous obliteration of the centrilobular hepatic veins. VOD after liver transplantation is a rare complication, with an incidence of approximately 2%; however, it...
Autores principales: | Lee, Tae Beom, Yang, Kwangho, Ko, Hyo Jung, Shim, Jae Ryong, Choi, Byung Hyun, Lee, Jung Hee, Ryu, Je Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238349/ https://www.ncbi.nlm.nih.gov/pubmed/34160449 http://dx.doi.org/10.1097/MD.0000000000026463 |
Ejemplares similares
-
Defibrotide for hepatic veno-occlusive disease
Publicado: (2021) -
Defibrotide in the treatment of hepatic veno-occlusive disease
por: Fulgenzi, Alessandro, et al.
Publicado: (2016) -
Influence of creatinine levels on survival in patients with veno-occlusive disease treated with defibrotide
por: Kong, Seom Gim, et al.
Publicado: (2022) -
Efficacy and Safety of Weight Reduction of the Donor in Hepatic Steatosis for Living Donor Liver Transplantation
por: Chung, Jae Hun, et al.
Publicado: (2020) -
A case report of severe veno-occlusive disease following autologous stem cell transplantation successfully treated with Defibrotide
por: Bahoush, Golamreza, et al.
Publicado: (2020)